USPTO serial 99753312
LUMINOS
Reviewed by CopyMark Law Group
Status 661
- Filing date
- Status date
- Registration date
- —
- Examiner
- WELCH, KATHERINE E
- Law office
- TMO LAW OFFICE 129
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with LUMINOS?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 042 | Scientific laboratory services in the field of genomics; Research and development services in the field of genomics; Research in the field of bioinformatics, namely, analysis and interpretation of genomic sequencing data; DNA sequencing technology research; Research in the field of DNA sequencing technology; Development of new technology for others in the field of genomics and molecular diagnostics; Scientific and technological services, namely, research and design in the field of next-generation sequencing and genomic data analysis; Scientific research in the nature of conducting clinical trials for others in the field of genomic medicine; Clinical laboratory testing services in the field of genomic profiling; Providing research laboratory analysis services in the field of genomics, namely, analysis of nucleic acids derived from human biological samples; Scientific laboratory services in the nature of genomic profiling services, namely, comprehensive next-generation sequencing of biological samples for use in clinical research and clinical trial support; Bioinformatics services, namely, analysis, interpretation, and reporting of genomic sequencing data derived from human biological samples; Medical research laboratory services in the field of genomic medicine; Medical laboratory services, namely, genomic profiling and DNA sequencing services for use in clinical research and clinical trials; Providing genomic testing services for clinical research purposes, namely, comprehensive analysis of nucleic acids derived from human biological samples to support patient stratification, biomarker identification, and companion diagnostic development; Medical laboratory services, namely, clinical genomic testing and reporting services for use in the diagnosis and monitoring of human disease | ACTIVE | — |
| 044 | Medical analysis services in the field of genomic medicine, namely, genomic profiling and next-generation sequencing for clinical diagnostic and clinical research applications | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 21, 2026 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Sep 21, 2026 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 21, 2026 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 18, 2026 | GAUN | NOTIFICATION OF NOTICE OF UNRESPONSIVE AMENDMENT - E-MAILED | — |
| Sep 18, 2026 | GAUD | NOTICE OF UNRESPONSIVE AMENDMENT - E-MAILED | — |
| Sep 18, 2026 | NAUD | REPORT UNRESPONSIVE AMENDMENT - COMPLETED | — |
| Sep 14, 2026 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Sep 14, 2026 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 14, 2026 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 3, 2026 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 3, 2026 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 3, 2026 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 18, 2026 | DOCK | ASSIGNED TO EXAMINER | — |
| Aug 16, 2026 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Apr 9, 2026 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Apr 9, 2026 | NWAP | NEW APPLICATION ENTERED | — |